Bedside Topline
- What It Does
- A pump and membrane oxygenator outside the body add gas exchange (VV) or gas exchange plus circulatory support (VA) while the patient is cannulated.
- Key Settings & Targets
- Flow: at least 60% of CO
- Sweep: titrate to PaCO₂ and pH
- FdO₂: lowest that meets the team's SpO₂ target (above 92% is the ELSO VV weaning threshold)
- Anti-Xa: 0.3–0.5 IU/mL per protocol
- Check Every Hour
- Flow, drainage and return pressures, sweep and FdO₂, cannula sites, distal limb perfusion (VA), neuro status and urine output.
- Top Alarm → First Move
- Low flow or suck-down (very negative drainage pressure): reduce pump speed, check position and volume, then call the ECMO team.
- Never
- Clamp or kink lines without an ECMO team order
- Let suck-down drop flow below 1 L/min at full pump speed
- Stop anticoagulation without a plan
- Escalate Now If
- Flow falls and does not recover
- New limb ischemia or neuro change
- Bleeding or dark urine (hemolysis)
- Pulmonary edema with low pulse pressure (VA)
Overview & How It Works
ECMO (extracorporeal membrane oxygenation, also called extracorporeal life support, ECLS) is a temporary circuit. It drains venous blood, runs it through a pump and a membrane oxygenator, and sends it back into the body. Venovenous (VV) ECMO supports gas exchange only. Venoarterial (VA) ECMO supports gas exchange and circulation. It is a bridge. It buys time for recovery or for a definitive therapy.
Key Components
| Component | Where It Sits | What It Does |
|---|---|---|
| Drainage cannula | Vena cava or right atrium | Draws venous blood into the circuit. Excess negative pressure causes suck-down |
| Centrifugal pump | Between drainage cannula and oxygenator | Sets blood flow (L/min). Higher flow adds shear and hemolysis risk |
| Membrane oxygenator | After the pump | Adds O₂ and removes CO₂. The integrated heat exchanger warms or cools blood |
| Gas blender and sweep | Feeds the oxygenator | FdO₂ sets oxygen content. Sweep gas flow sets CO₂ removal |
| Return cannula | Vein (VV) or artery (VA) | Determines whether ECMO supports the lungs only or the heart and lungs |
Flow Path
- Patient: venous blood drains through the drainage cannula.
- Pump: the centrifugal pump moves blood at the set flow.
- Oxygenator: gas exchange and temperature control happen here. Sweep gas carries CO₂ away.
- Return: blood goes back into a vein (VV) or an artery (VA).
- Sampling: pressures and blood gases before and after the oxygenator show each stage.
Physiology & Hemodynamic Effects
What It Does
| Parameter | Effect | Why It Matters |
|---|---|---|
| ECMO flow | ↑ systemic O₂ delivery | Higher flow raises oxygen delivery but adds shear and hemolysis risk. High flow with low circulating volume causes suck-down |
| Recirculation | ↑ returned blood redrawn; SaO₂ ↓ | Oxygenated blood from the return cannula is pulled back into the drainage cannula and never reaches the lungs |
| Native cardiac output (CO) | ↑ with fever or sepsis | Native lungs and heart deliver more unoxygenated blood, so SaO₂ falls even at high ECMO flow |
| FdO₂ (oxygenator) | ↑ arterial PaO₂ (VV) | Adds oxygen content. Titrate to the lowest value that meets targets; avoid hyperoxia |
| Sweep gas flow | ↑ CO₂ removal | Lowers PaCO₂ quickly. A rapid fall in CO₂ is associated with neurologic injury |
| Retrograde flow (VA) | ↑ aortic afterload | The LV ejects less, the aortic valve may stay closed, and the LV can distend with pulmonary edema |
| Ventilator tidal volume and pressure | ↓ needed on ECMO | The circuit does most of the gas exchange, so the lungs can rest at lower pressures |
What It Depends On
- Cannula size and position: the cannula caps achievable flow and sets the drainage pressure.
- Native cardiac output and lung function: decide how much blood skips the circuit's oxygenator.
- Hemoglobin: oxygen content depends on it just as much as on flow (see Calculations).
- Volume status and intrathoracic pressure: shift the drainage pressure and the risk of suck-down.
- Native LV contractility (VA): sets the pulse pressure and decides whether the LV distends.
Types, Modes & Configurations
| Type / Mode | Route / Configuration | Support or Output | Best For | Key Limitation / Risk |
|---|---|---|---|---|
| VV ECMO | Vein drained; oxygenated blood returned to a vein (dual-lumen or two-site) | Gas exchange only; the native heart still pumps | Refractory hypoxemia or hypercapnia with a working heart | Recirculation; flow limited by cannula size; no circulatory support |
| Peripheral VA | Femoral or axillary drainage; return to femoral or axillary artery | Gas exchange and circulation | Cardiogenic shock, ECPR, post-cardiotomy failure | LV afterload and distension; limb ischemia; differential hypoxemia (Harlequin) |
| Central VA | Surgical cannulas (right atrium to aorta) | Gas exchange and circulation | Post-cardiotomy shock and surgical access | Requires surgical access; bleeding; sternal closure planning |
| Hybrid (VAV or VVA) | Two drainage or return sites | Variable | Selected cases with differential oxygenation | Complex; ELSO advises VAV cannulation only if necessary |
| ECPR | Peripheral cannulation during CPR | Circulation during arrest | Refractory VF/pVT arrest, under local criteria | Low-flow time; neurologic outcome; cannulation during CPR |
Cannulation Concept
VV ECMO is commonly set up one of two ways. One is a dual-lumen cannula. The other is separate drainage and return sites. Peripheral VA runs through femoral or axillary vessels. A femoral arterial cannula needs a distal perfusion catheter in the same limb. The ECMO team picks the configuration, based on the underlying cause and the vascular anatomy.
Mode Settings to Know
- VV ECMO: you set flow, sweep and FdO₂. The ventilator goes to lung-rest levels (see Setup, Settings & Targets).
- VA ECMO: flow, the MAP target and the LV assessment drive the settings. Pulse pressure shows native contractility.
- ECPR: cannulation happens during CPR, under the local ECPR protocol. Keep external compressions going through the whole cannulation. ELSO recommends that.
Indications, Contraindications & Evidence
Indications
- VV ECMO, hypoxemic failure: PaO₂/FiO₂ below 80 mmHg after optimal care, including a trial of prone positioning if no contraindication (ELSO VV guideline).
- VV ECMO, hypercapnic failure: pH below 7.25 despite optimal ventilation (rate 35 breaths/min, plateau pressure 30 cmH₂O or less).
- VV ECMO, bridge: bridge to lung transplantation or primary graft dysfunction after lung transplant.
- EOLIA entry criteria (very severe ARDS): with optimized ventilator settings, PaO₂/FiO₂ below 50 mmHg for more than 3 hours, PaO₂/FiO₂ below 80 mmHg for more than 6 hours, or pH below 7.25 with PaCO₂ of at least 60 mmHg for more than 6 hours.
- VA ECMO: refractory cardiogenic shock with a potentially reversible or surgically correctable cause, massive pulmonary embolism, fulminant myocarditis, post-cardiotomy shock, bridge to decision, transplant or durable LVAD, and ECPR under local criteria (ELSO VA guideline). VA ECMO is a bridge, not destination therapy. Plan the route from the start: recovery, decision, transplant or durable LVAD. Routine early VA ECMO in infarct-related shock did not lower mortality in randomized trials. Selection is individual (see Key Evidence).
Contraindications
| Consideration | VV (ELSO guidance 2021) | VA (ELSO guidance 2021) |
|---|---|---|
| Intracranial hemorrhage or significant brain injury | Relative contraindication | Acute brain injury is listed as a contraindication |
| Systemic bleeding or contraindication to anticoagulation | Relative contraindication | Managed case by case with the ECMO team |
| Immunosuppression | Relative contraindication | Immunocompromise is listed |
| Age | No threshold; risk rises with age | Age alone is not an absolute contraindication |
| Ventilation more than 7 days with plateau pressure above 30 cmH₂O and FiO₂ above 90% | Relative contraindication | Not listed |
| Cardiac recovery unlikely with no transplant or LVAD option | Not applicable | Listed |
| Acute Type A or B aortic dissection with extensive aortic and branch involvement (preoperatively) | Not addressed here | Listed |
| Severe neurologic impairment (prolonged anoxic brain injury, extensive trauma or bleeding) | Not addressed here | Listed |
| Liver cirrhosis (Child-Pugh class B and C) | Not addressed here | Listed |
| Severe aortic regurgitation | Not applicable | Listed |
| Severe vascular disease, including axillary arteries | Not applicable | Listed |
| End-stage organ disease or malignancy with poor life expectancy | Not applicable | Listed |
ECPR Candidacy (Example Criteria)
ELSO's adult ECPR interim guideline lists these as example inclusion criteria. Agree on local criteria in advance. The trial populations are narrow, and resources are limited.
- Age under 70 years, witnessed arrest, and bystander CPR started within 5 minutes.
- Initial rhythm of VF, pVT or PEA, with ECMO flow established within 60 minutes (the "low-flow interval").
- End-tidal CO₂ above 10 mmHg during CPR before cannulation.
- No known life-limiting comorbidity, and no more than mild aortic valve incompetence.
Key Evidence
| Trial / Guideline (Year) | Population | Bottom Line |
|---|---|---|
| EOLIA (2018, landmark trial) | Adults with very severe ARDS meeting the entry criteria above | 60-day mortality was 35% with VV ECMO versus 46% with conventional care. The difference was not statistically significant |
| ARREST (2020) | Adults aged 18 to 75 with refractory VF out-of-hospital arrest (single-center trial, 30 patients) | Survival to discharge was 43% (6 of 14) with ECMO-facilitated resuscitation versus 7% (1 of 15) with standard ACLS. The trial was stopped at an interim analysis and is small, so treat it as hypothesis-generating |
| INCEPTION (2023) | Adults aged 18 to 70 with out-of-hospital arrest, bystander CPR and an initial VT/VF rhythm | Early ECPR did not significantly improve favorable neurologic outcome at 30 days (20%, 14 of 70, versus 16% with conventional CPR) |
| ECLS-SHOCK (2023, randomized) | Adults with infarct-related cardiogenic shock | Early routine VA ECLS did not lower 30-day mortality (47.8% in the ECLS group). Moderate or severe bleeding occurred in 23.4% and limb complications needing intervention in 11.0% (3.8% in the control group). Routine use is not supported for MI shock |
| ECMO-CS (2023, randomized) | Adults with cardiogenic shock | All-cause mortality was 50.0% with ECMO versus 47.5% without (no significant difference). Bleeding was not statistically different |
| ELSO VV guideline (2021) | Adults on VV ECMO | Sets lung-rest ventilator targets, the ECMO flow fraction of cardiac output, and the transfusion question (contested) |
| ELSO VA interim guideline (2021) | Adult cardiac patients on VA ECMO | Sets LV distension, pulse pressure, and weaning criteria (see Weaning) |
Setup, Settings & Targets
| Parameter | Typical Target | If Below | If Above |
|---|---|---|---|
| ECMO flow | ≥60% of CO (usual VV maximum 5–6 L/min, cannula-dependent) | SaO₂ falls; check cannula, volume and recirculation | Higher shear and hemolysis; drainage pressure falls |
| SpO₂ (VV) | Set by the ECMO team; above 92% is the ELSO VV weaning threshold; 92–97% in ECPR | Recirculation or low flow; increase flow or FdO₂ per protocol | Hyperoxia risk; reduce FdO₂ to the lowest effective value |
| Sweep and PaCO₂ | Normal pH; change sweep slowly | Hypercapnia: increase sweep | Rapid CO₂ drop is linked with neurologic injury |
| MAP (VA) | Individualized; ELSO uses the lowest acceptable MAP when the LV is overloaded and MAP above 65 mmHg for weaning | Organ perfusion falls | Afterload rises; LV distension risk |
| Pulse pressure (VA) | Above 10 mmHg indicates native LV ejection | Loss of pulsatility; LV distension risk | — |
| Anti-Xa (UFH) | 0.3–0.5 IU/mL (ELSO adult table) | Clot risk; oxygenator clot | Bleeding risk |
Initial Settings
- VV lung-rest ventilator: plateau pressure below 25 cmH₂O (acceptable up to 30), PEEP at least 10 cmH₂O, set rate 4 to 15 breaths/min, and FiO₂ as low as keeps saturation adequate (ELSO VV Table 3).
- Sweep: set the starting rate per protocol and adjust slowly to reach the PaCO₂ and pH target.
- Flow: increase toward at least 60% of cardiac output, within what the cannula and drainage pressure allow.
- Anticoagulation: start per the local protocol and adjust to the target in the Anticoagulation section.
Sizing and Positioning
- Cannulation guidance: ELSO recommends ultrasound for percutaneous cannulation (ELSO VA guideline).
- Distal perfusion catheter: with femoral arterial return, place it at cannulation. Where flow can be measured, aim for at least 100 mL/min (ELSO VA guideline).
- Cannula size: sets the flow ceiling. The ECMO team chooses size and sites (typical; follow institutional protocol).
Calculations & Derived Values
| Variable | Formula or Source | Target / Normal | Why You Care |
|---|---|---|---|
| CaO₂ | Oxygen content from Hb, SaO₂ and PaO₂ (above) | Depends on Hb and saturation | Shows what the blood carries, not just the flow |
| Systemic O₂ delivery | Flow × CaO₂ (indexed to body surface area) | At least 300 mL/m²/min to meet rest needs (ELSO VV) | Sets whether tissues receive enough oxygen |
| ECMO flow fraction | Flow ÷ cardiac output × 100 | At least 60% (VV) | Below this, SaO₂ often falls |
Waveforms & Console Interpretation
Normal
- Drainage (pre-pump) pressure: negative. It gets more negative as flow rises or volume falls. Watch for a rapid swing.
- Pre- and post-oxygenator pressures: watch the difference, the oxygenator pressure drop. It changes slowly. A rising drop suggests clot.
- Arterial pulse pressure (VA): reflects native LV ejection. Lost pulsatility suggests the LV is not ejecting.
- Paired blood gases: compare pre- and post-oxygenator samples to estimate recirculation.
| Pattern | What You See | Likely Cause | First Action |
|---|---|---|---|
| Suck-down | Flow drops more than 1–2 L/min below baseline (ELSO VV); drainage pressure very negative; line chatter | Low circulating volume, cannula against the wall, high intra-abdominal pressure | Reduce pump speed rapidly; check cannula position and volume; adjust ventilator; call the ECMO team |
| Rising oxygenator pressure drop | Pressure difference across the oxygenator climbs over time | Clot in the oxygenator | Notify the ECMO team; prepare for circuit change per protocol |
| Lost pulsatility (VA) | Flat arterial trace; pulse pressure falls | LV not ejecting; rising afterload | Assess for LV distension with echo; lowest acceptable MAP; call the team |
| Recirculation | Pre-oxygenator SaO₂ high; post-oxygenator sample normal; systemic SaO₂ low | Cannula malposition or drainage close to return | Check cannula position; reposition per the ECMO team |
| Differential hypoxemia (VA) | Right radial SpO₂ or PaO₂ lower than femoral values | Native lungs eject poorly oxygenated blood via the LV | Improve lung oxygenation; adjust return site per the team |
Monitoring & Ongoing Care
| Frequency | What to Check | Expected / Action Threshold |
|---|---|---|
| Hourly | Flow, pump speed, drainage and return pressures, sweep and FdO₂, cannula sites, distal limb perfusion (VA), neuro status, urine output | Flow at or above the agreed target; no suck-down or chatter; distal perfusion present; new deficits escalated |
| Every 4–6 h | Pre- and post-oxygenator blood gases, Hb, platelets, fibrinogen, anti-Xa or aPTT, plasma free Hb, LDH, lactate, electrolytes (K⁺, iCa²⁺) | Targets in Anticoagulation and Transfusion. Plasma free Hb above 50 mg/dL makes anti-Xa unreliable (typical; follow protocol) |
| Every 12–24 h | Echo or ultrasound for LV function and aortic valve opening (VA); chest X-ray for cannula position; ventilator reassessment | Aortic valve opening and LV size guide unloading and weaning |
| Daily | Mobility plan, sedation depth, fluid balance, and weaning readiness | Set the plan for weaning and mobilization with the ECMO team |
Positioning and Mobility
- Keep a femoral cannulated limb straight. Avoid hip flexion beyond the limit the cannula site sets.
- Check distal pulses, Doppler signals or capillary refill every hour, and after any move.
- Mobilize as far as the cannula setup and team consensus allow.
Daily Checklist
- Confirm mode (VV or VA), cannula sites and flow direction.
- Review flow, pressures, oxygenator pressure drop and any upward trend.
- Review sweep, FdO₂, ventilator settings and the most recent blood gases.
- Assess MAP, pulse pressure, vasoactive support, lactate and urine output.
- Inspect cannula sites and limb perfusion.
- Review anticoagulation, Hb, platelets, fibrinogen, plasma free Hb and electrolytes.
- Assess neuro status, sedation depth and mobility plan.
Anticoagulation & Hematology
Strategy and Targets
| Strategy / Agent | Typical Target | Monitoring | Watch For |
|---|---|---|---|
| Unfractionated heparin (UFH) | Anti-Xa 0.3–0.5 IU/mL is the first goal row in the ELSO adult table; 0.4–0.6 and 0.5–0.7 are also listed | Anti-Xa (preferred); aPTT is less specific; ACT and viscoelastic tests per local protocol | Falsely low anti-Xa with plasma free Hb above 50 mg/dL, triglycerides above 500 mg/dL or bilirubin above 6 mg/dL. Antithrombin changes the response |
| No anticoagulation | Not routine | Frequent circuit and thrombus checks | ELSO does not yet recommend routine no-anticoagulation for VV ECMO. VA evidence is retrospective |
| Bivalirudin or argatroban | Per protocol (heparin-induced thrombocytopenia or heparin intolerance) | aPTT or direct thrombin inhibitor assay | No antidote. Bivalirudin has a short adult half-life (about 25 min); argatroban is cleared by the liver (about 39–51 min) |
| Hypothermia ECLS rewarming | UFH anti-Xa 0.2–0.3 IU/mL, or ACT 150–180 s (ELSO guidance 2025) | ACT, aPTT ratio 1.5–2, anti-Xa | Lower anti-Xa range than the adult table. Follow the protocol for hypothermia |
Hemolysis
- Causes: high flow, suck-down, pump-head or oxygenator clot, and cannula shear.
- Tests: plasma free hemoglobin, LDH, haptoglobin and bilirubin, plus dark or red urine.
- Action: check the circuit and pump, reduce flow to the lowest effective level, and call the ECMO team about circuit change.
Bleeding and Transfusion Goals
Bleeding risk climbs on long runs with anticoagulation. Acquired von Willebrand syndrome (loss of large multimers) and fibrinogen changes increase it (ELSO VA guideline). The ELSO 2021 anticoagulation guideline sets these blood product goals.
| Product | Nonbleeding Goal | Bleeding Goal |
|---|---|---|
| Platelets | At least 50–100 × 10⁹/L (50,000–100,000/µL) | At least 100 × 10⁹/L (100,000/µL) |
| Fibrinogen | Above 1 g/L (100 mg/dL) | Above 1.5 g/L (150 mg/dL) |
| INR | Below 3 | Below 1.5 |
| Hemoglobin | 70–90 g/L (7–9 g/dL); lower end for stable adults | Per the ECMO team |
Antithrombin and HIT
Consider antithrombin replacement when heparin requirement runs high and anticoagulation targets are still missed. Routine antithrombin monitoring is not established (ELSO guidance 2021). With heparin-induced thrombocytopenia, reach for a direct thrombin inhibitor under local protocol.
Key Medications & Drug Considerations
| Medication | Role Here | Typical Adult Dose / Target | Device-Specific Notes |
|---|---|---|---|
| Heparin (UFH) | Circuit anticoagulant | Infusion titrated to anti-Xa 0.3–0.5 IU/mL; dose per protocol | High-alert Falsely low anti-Xa with high plasma free Hb. See heparin |
| Bivalirudin or argatroban | Alternative to heparin (HIT or intolerance) | Per protocol; no E3 medication page yet | High-alert No antidote. Argatroban is hepatically cleared |
| Propofol | Sedation | Per medication page, titrated to sedation target | High-alert Lipophilic drugs can be sequestered by the circuit. See propofol |
| Midazolam | Sedation | Per medication page | High-alert See midazolam |
| Dexmedetomidine | Sedation adjunct | Per medication page | High-alert IV moderate sedation agent (ISMP). Watch heart rate and blood pressure. See dexmedetomidine |
| Fentanyl | Analgesia | Per medication page | High-alert Opioid. See fentanyl |
| Norepinephrine | Vasopressor for MAP target (VA) | Per medication page; titrate to MAP | High-alert ELSO advises avoiding vasopressors where possible when the LV is overloaded. See norepinephrine |
| Vasopressin | Vasopressor adjunct | Per medication page | High-alert See vasopressin |
| Milrinone or dobutamine | Small-dose inotrope to encourage LV ejection | Per medication page | High-alert ELSO VA advises a small dose. See milrinone or dobutamine |
| Protamine | Heparin reversal for major bleeding | Per protocol | High-alert Boxed warning: severe hypotension, cardiovascular collapse, noncardiogenic pulmonary edema and pulmonary hypertension. Vasopressors and resuscitation equipment should be at hand. Do not give for bleeding without prior heparin. See protamine |
| Tranexamic acid | Antifibrinolytic for bleeding | Per protocol | ELSO notes antifibrinolytics may raise thrombosis risk. See tranexamic acid |
Sequestration by the circuit differs from drug to drug. ECMO dosing data are thin, so titrate to effect and check the medication page.
Alarms & Troubleshooting
| Alarm / Problem | What You See | Likely Causes | First Actions |
|---|---|---|---|
| Low flow / suck-down | Flow falls more than 1–2 L/min; drainage pressure very negative | Low volume; cannula position; high intrathoracic pressure | 1) Reduce pump speed rapidly. 2) Check position, volume and ventilator. 3) Slowly restore flow and call the ECMO team |
| Line chatter | Visible tubing vibration; intermittent flow | Cannula against the vessel wall; relative hypovolemia | 1) Lower flow temporarily. 2) Adjust position and volume. 3) Call the team |
| Hypoxemia | SaO₂ falls despite high flow | Recirculation; high native CO (fever, sepsis); lung injury | 1) Check cannula position and pre/post-oxygenator gases. 2) Treat fever or sepsis. 3) Adjust FdO₂ and ventilator |
| Hypercapnia | PaCO₂ rising; pH falling | Low sweep flow; oxygenator performance; high CO₂ production | 1) Increase sweep gradually. 2) Check the oxygenator. 3) Control fever and agitation |
| Rising oxygenator pressure drop | Pressure across oxygenator climbs | Clot in the oxygenator | 1) Notify the ECMO team. 2) Check anticoagulation. 3) Prepare for circuit change per protocol |
| Gas supply or power loss | Gas or power alarm | Gas or power interruption | 1) Switch to backup power or supply. 2) Restore gas. 3) Call the team |
| Air in the circuit | Bubble or air alarm | Line disconnection; priming error | 1) Stop the pump and follow the air protocol. 2) Clamp per team instructions. 3) Call the team |
| Limb ischemia (VA) | Cool, pale, painful or pulseless limb; Doppler loss | Arterial cannula compromises distal flow | 1) Urgent vascular assessment. 2) Restore distal flow. 3) Call the team |
Complications & Red Flags
| Complication | How You Recognize It | Immediate Action | Prevention |
|---|---|---|---|
| Limb ischemia (VA) | Cool, pale or painful limb; loss of Doppler signal | Urgent vascular assessment; call the team | Distal perfusion catheter; check limb every hour |
| Bleeding | Cannula site or GI bleeding; falling Hb; neuro change | Reduce or hold heparin per team; transfuse to goals; neuro check | Anticoagulation within target; watch for acquired von Willebrand syndrome |
| Hemolysis | Plasma free Hb above 50 mg/dL; LDH rising; dark urine | Check pump and flow; reduce flow; call the team | Avoid high flow and suck-down; check circuit |
| Thrombosis or embolism | Rising oxygenator pressure; pump clot; stroke signs | Notify team; urgent imaging per protocol | Anticoagulation monitoring; avoid stasis |
| Neurologic injury | New focal deficit; sudden change in exam | Urgent neuro evaluation; call the team | Avoid rapid fall in PaCO₂; anticoagulation within target |
| LV distension (VA) | Pulmonary edema; pulse pressure below 5–10 mmHg; closed aortic valve on echo | Lowest acceptable MAP; inotrope; LV unloading per team | Early echo; monitor pulse pressure |
| Differential hypoxemia (VA) | Right radial SpO₂ or PaO₂ lower than femoral | Improve lungs; adjust flow or return site per team | Right radial and right upper body monitoring |
| Air embolism | Sudden hemodynamic change; air in line | Stop the pump and follow the air protocol | Priming and connection checks; bubble detection |
Emergencies: Arrest, Power Loss & Device Failure
Cardiac Arrest on ECMO
- Start CPR per the local ECLS arrest protocol. ELSO recommends continuing external compressions throughout cannulation (ECPR).
- Call the ECMO team and the ECPR team early. Cannulation aims for adequate flow within 60 minutes of arrest (ELSO ECPR interim guideline).
- Defibrillate per your ACLS protocol, with extreme caution once guidewire insertion has started (ELSO ECPR interim guideline). Stop epinephrine boluses as the circuit is connected (risk of severe hypertension once flow starts). Mechanical compressions can stop once VA ECMO flow is 3 L/min or more (ELSO ECPR interim guideline).
- After return of circulation: target SpO₂ 92–97% and temperature management at 33–36°C for 24 hours, then gradual rewarming to 37°C (ELSO ECPR interim guideline). These ELSO values are consensus targets, so follow your receiving center's post-arrest protocol where they differ.
- Coronary angiography: ELSO recommends emergent angiography for ECPR patients without an obvious noncardiac cause.
Power or Console Failure
- Switch to backup power and keep the pump running at the set flow if the backup supply allows.
- Call the ECMO team and bring the backup console or drive per your program's protocol.
- Keep the patient ventilated and oxygenated while the team restores the circuit.
Cannula Dislodgement or Decannulation
- Apply direct pressure to the site and call for help.
- Do not remove the cannula unless the ECMO or surgical team directs it.
- Clamp in the team's sequence (surgeon or ECMO specialist). Check the limb after any change.
Air in the Circuit
- Stop the pump and follow the air protocol.
- Clamp per the ECMO team and remove the air from the circuit.
- Check the patient for air embolism signs and support oxygenation.
Oxygenator Failure
- Check the gas supply, sweep gas connections and the oxygenator pressures.
- Call the ECMO team for circuit change per protocol.
- Support the patient with ventilation and oxygenation while the circuit is changed.
Weaning & Discontinuation
Readiness Criteria
- VA: MAP above 65 mmHg, pulse pressure above 10 mmHg, and mixed venous saturation adequate at 2 to 2.5 L/min of ECMO flow (ELSO VA guideline).
- VV: SpO₂ above 92% or PaO₂ at least 70 mmHg while FdO₂ and sweep are reduced (ELSO VV guideline).
- Cause treated: echo, chest X-ray and labs show the reason for ECMO has improved.
Weaning Steps
- VA ECMO: reduce flow in serial steps, with echo and hemodynamic assessment at each stage, until about 0.5–1.0 L/min is reached (ELSO ECPR interim guideline). Protocol sets the lowest flow used before decannulation.
- VV ECMO: reduce FdO₂ from 1.0 to 0.21 in steps of about 20%, keeping SpO₂ above 92%. Then reduce sweep by 0.5 to 1 L/min toward 1 L/min, checking an ABG at each step.
- Off-sweep challenge (VV): trial off sweep gas for 2 to 3 hours or longer, with SpO₂ and ABG monitoring (ELSO VV guideline).
- Hypothermia ECLS: attempt weaning once core temperature is above 35°C and echo shows improved LV ejection. Reduce flow to 50%, then 25% of adequate cardiac output (ELSO guidance 2025).
Failure Criteria: Step Back Up
- Falling MAP, rising lactate or falling mixed venous saturation during a trial.
- Worsening LV function, falling pulse pressure or new pulmonary edema on echo or chest X-ray.
- SpO₂ falling as FdO₂ or sweep is reduced.
Removal and Post-Removal Care
- The surgical or ECMO team does the decannulation. Large-bore cannulas come out surgically (ELSO VA guideline).
- Check hemostasis, distal pulses and limb perfusion after removal, and continue monitoring per team protocol.
- After decannulation, ELSO recommends a vessel ultrasound to check for thrombosis (ELSO VA guideline).
Transport Considerations
Before You Move
- Confirm console battery and backup power for the planned transport time, per the manufacturer and your program.
- Confirm gas supply and cylinder duration for the full trip.
- Secure every line: drainage, return, ventilator, monitoring and infusions. Tape or dress cannula sites.
- Carry the spare equipment your program requires, including clamps and backup supplies.
- Confirm that a trained ECMO team member or trained RN travels with the patient.
- Brief the receiving team on mode, flows, sweep, anticoagulation and recent alarms.
If You Are Not the Device Specialist
- Watch: flow, drainage pressure, SpO₂, MAP and limb perfusion.
- Never touch: pump speed, sweep, FdO₂, or clamps, unless the ECMO team has ordered it.
- Call: the ECMO team at the first sign of flow change, bleeding or limb change.
- Arrest: start CPR per your local ECLS protocol and keep the circuit intact.
- ECPR candidates: note the time of arrest, the time CPR started and the ETCO₂ during CPR. Report all three to the receiving ECPR team. ELSO example criteria use these numbers: low-flow time under 60 minutes, ETCO₂ above 10 mmHg.
During Transport
- Hold the console at the set flow. Position the circuit so tubing is not kinked or stretched.
- Recheck cannula sites, limb perfusion and lines after every move, bump or position change.
- Expect alarms during movement. Stop. Assess the patient, then the circuit.
Air Medical and Altitude
Altitude changes the gas volumes in the lungs and in the circuit. How you respond is program-specific. Before departure, follow your air medical program's ECMO altitude plan, agreed with the ECMO team.
Handoff
- Mode, cannula sites and flow.
- Sweep, FdO₂, ventilator settings and latest gases.
- Anticoagulation agent, target, and recent bleeding or transfusion.
- Recent alarms, complications and limb checks.
- Goals of care and the weaning or escalation plan.
Special Populations
Pediatric and Neonatal
- VA flow: ELSO pediatric cardiac failure guidance aims for a cardiac index of 2.5–3 L/min/m². That is about 100–150 mL/kg/min in infants and 70–100 mL/kg/min in larger children.
- Shunt physiology: single-ventricle physiology with a systemic-to-pulmonary shunt may need higher flow. In neonates, that is about 150–200 mL/kg/min (ELSO pediatric guidance).
- Scope: this page does not cover pediatric or neonatal respiratory ECMO. For those, use the specialist center and ELSO guidance.
- Pediatric drug doses are weight-based. See weight-based dosing, and shock in children for the pediatric approach to cardiogenic shock.
Pregnancy and Peripartum
- Unique indications: peripartum cardiomyopathy, amniotic fluid embolism and eclampsia syndromes (ELSO 2025 pregnancy guideline).
- Gas goals: pH above 7.3, PaCO₂ 30–40 mmHg, PaO₂ above 70 mmHg.
- Heparin: it does not cross the placenta. Pause circuit heparin for anyone suspected of being in labor or bleeding.
- Cardiac arrest: in an experienced center, cannulate during or right after resuscitative hysterotomy. CPR continues throughout.
Accidental Hypothermia
- Indication: hypothermic cardiac arrest. ECLS is considered mainly when core temperature is below 30°C and HOPE-estimated survival is at least 10% (ELSO guidance 2025). Temperature alone does not decide eligibility.
- Rewarming: up to 5°C per hour, until 30°C or return of circulation. Keep the venous-to-arterial temperature gradient at 4°C or less (ELSO guidance 2025).
- Cannulation: for emergency access, femoral-femoral VA with a distal perfusion cannula is preferred. Do not delay for CT.
Other
Age is not, on its own, an absolute contraindication to VA ECMO (ELSO VA guideline). Weigh prognostic scores and local criteria with the ECMO team.
Bedside Pearls & Teaching Script
Systematic Walk-Through
- Indication: VV for lungs or VA for heart and lungs?
- Mode and cannulas: where are they, and which flow is set?
- Settings: flow, sweep, FdO₂, ventilator and MAP target.
- Anticoagulation: agent, target and latest results.
- Complications: limb, bleeding, hemolysis, neurologic and LV status.
- Today's goal: wean, adjust, mobilize or escalate.
Pearls
- On VV ECMO, the usual reasons SaO₂ stays low despite high flow are recirculation and high native cardiac output (ELSO VV guideline).
- On VA ECMO, pulse pressure is your bedside sign of native LV contraction.
- Anti-Xa can read falsely low when plasma free hemoglobin runs high.
- Protect the lungs during VV ECMO: the circuit does the gas exchange.
- For a femoral arterial cannula, distal perfusion is the first line of protection.
References
- Combes, A., et al. (2018). Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome (EOLIA trial). New England Journal of Medicine, 378, 1965–1975. https://doi.org/10.1056/NEJMoa1800385
- Yannopoulos, D., et al. (2020). Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST trial). The Lancet, 396, 1807–1816. https://doi.org/10.1016/S0140-6736(20)32338-2
- Suverein, M. M., et al. (2023). Early extracorporeal CPR for refractory out-of-hospital cardiac arrest (INCEPTION trial). New England Journal of Medicine, 388, 299–309. https://doi.org/10.1056/NEJMoa2204511
- Tonna, J. E., et al. (2021). Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): Guideline from the Extracorporeal Life Support Organization (ELSO). ASAIO Journal, 67, 601–610. https://doi.org/10.1097/MAT.0000000000001432
- Lorusso, R., et al. (2021). ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO Journal, 67, 827–844. https://doi.org/10.1097/MAT.0000000000001510
- Richardson, A. S. C., et al. (2021). Extracorporeal cardiopulmonary resuscitation in adults: Interim guideline consensus statement from ELSO. ASAIO Journal, 67, 221–228. https://doi.org/10.1097/MAT.0000000000001344
- McMichael, A. B. V., et al. (2022). 2021 ELSO adult and pediatric anticoagulation guidelines. ASAIO Journal, 68, 303–310. https://doi.org/10.1097/MAT.0000000000001652
- Cools, E., et al. (2025). ELSO 2025 narrative guideline on the use of ECMO for accidental hypothermia. ASAIO Journal, 71, 865–874. https://www.elso.org/Portals/0/files/Guideline/elso_2025_narrative_guideline_on_the_use_of_ecmo.818-1.pdf
- O'Neil, E. R., et al. (2025). ELSO 2025 narrative guideline on pregnant and peripartum extracorporeal membrane oxygenation. ASAIO Journal. https://www.elso.org/Portals/0/files/Guideline/elso_2025_narrative_guideline_on_pregnant_and.802.pdf
- Extracorporeal Life Support Organization (ELSO) (2021). Guidelines for pediatric cardiac failure [PDF]. ELSO. https://www.elso.org/Portals/0/files/pdf/Extracorporeal_Life_Support_Organization__ELSO__Pediatric_cardiac_failure.pdf
- Thiele, H., et al. (2023). Extracorporeal life support in infarct-related cardiogenic shock. New England Journal of Medicine, 389, 1286–1297. https://doi.org/10.1056/NEJMoa2307227
- Ostadal, P., et al. (2023). Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO-CS randomized clinical trial. Circulation, 147, 454–464. https://doi.org/10.1161/CIRCULATIONAHA.122.062949
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.